{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2022-P-0614\" sorted by posted_date descending", "rows": [["FDA-2022-P-0614-0007", "FDA", "FDA-2022-P-0614", "Response Letter from FDA CDER to Yichang Humanwell Pharmaceuticals, LLC", "Other", "Response(s)", "2022-12-21T05:00:00Z", 2022, 12, "2022-12-21T05:00:00Z", null, "2022-12-21T18:21:19Z", null, 0, 0, "0900006485549f61"], ["FDA-2022-P-0614-0006", "FDA", "FDA-2022-P-0614", "Determination That ZYBAN (Bupropion Hydrochloride) Tablets, Extended\nRelease, 150 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2022-12-21T05:00:00Z", 2022, 12, "2022-12-21T05:00:00Z", null, "2022-12-21T15:58:45Z", "2022-27647", 0, 0, "0900006485548d58"], ["FDA-2022-P-0614-0005", "FDA", "FDA-2022-P-0614", "Interim Response Letter from FDA CDER to Yichang Humanwell Pharmaceuticals LLC", "Other", "Letter(s)", "2022-10-26T04:00:00Z", 2022, 10, "2022-10-26T04:00:00Z", null, "2022-10-26T12:25:39Z", null, 0, 0, "090000648545ccbf"], ["FDA-2022-P-0614-0004", "FDA", "FDA-2022-P-0614", "Attachment 2 - Cumulative Supplement of the Orange Book - July 2019 - re: Citizen Petition from Yichang Humanwell Pharmaceutical Co. Ltd.", "Supporting & Related Material", "Background Material", "2022-04-19T04:00:00Z", 2022, 4, null, null, "2022-04-19T17:43:37Z", null, 0, 0, "0900006485023c43"], ["FDA-2022-P-0614-0002", "FDA", "FDA-2022-P-0614", "Acknowledgment Letter from FDA DMS to Yichang Humanwell Pharmaceutical Co. Ltd.", "Other", "Acknowledgement Letter/Receipt", "2022-04-19T04:00:00Z", 2022, 4, "2022-04-19T04:00:00Z", null, "2022-04-19T17:43:20Z", null, 0, 0, "0900006485023f43"], ["FDA-2022-P-0614-0001", "FDA", "FDA-2022-P-0614", "Citizen Petition from Yichang Humanwell Pharmaceutical Co., Ltd.", "Other", "Citizen Petition", "2022-04-19T04:00:00Z", 2022, 4, "2022-04-19T04:00:00Z", null, "2022-12-21T17:09:54Z", null, 0, 0, "0900006485023ad5"], ["FDA-2022-P-0614-0003", "FDA", "FDA-2022-P-0614", "Attachment 1- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations - re: Citizen Petition from Yichang Humanwell Pharmaceutical Co. Ltd.", "Supporting & Related Material", "Background Material", "2022-04-19T04:00:00Z", 2022, 4, null, null, "2022-04-19T17:43:30Z", null, 0, 0, "0900006485023c3c"]], "truncated": false, "filtered_table_rows_count": 7, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2022-P-0614"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2022-P-0614", "results": [{"value": "FDA", "label": "FDA", "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2022-P-0614", "results": [{"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2022-P-0614", "results": [{"value": 2022, "label": 2022, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&posted_year=2022", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2022-P-0614&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 11.971759027801454, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}